ACETAMINOPHEN CAPSULES 500MG (MINIS-RED OPAQUE)

ACETAMINOPHEN CAPSULES 500MG (MINIS-RED OPAQUE) was reported 103 times

ACETAMINOPHEN CAPSULES 500MG (MINIS-RED OPAQUE) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTICOAGULANT THERAPY 1 0.0035
1 WHITE BLOOD CELL COUNT 1 0.0034
2 OESOPHAGEAL INFECTION 1 0.0022
3 POSTNASAL DRIP 1 0.0018
4 BLOOD BILIRUBIN DECREASED 1 0.0016
5 INTESTINAL FUNCTIONAL DISORDER 1 0.0016
6 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1 0.0015
7 ARTHROSCOPY 1 0.0015
8 HEART TRANSPLANT 1 0.0011
9 BONE CONTUSION 1 0.0011
10 PROSTATE INFECTION 1 0.0010
11 OROPHARYNGEAL SWELLING 1 0.0010
12 BLOODY DISCHARGE 1 0.0009
13 IMPLANTABLE DEFIBRILLATOR INSERTION 1 0.0008
14 HYPOSMIA 1 0.0007
15 SKIN HYPOPIGMENTATION 1 0.0006
16 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
17 PANCREATIC CYST 1 0.0005
18 HYPOGEUSIA 1 0.0005
19 RHEUMATIC FEVER 2 0.0004
20 INFECTIOUS MONONUCLEOSIS 1 0.0004
21 URINARY TRACT DISORDER 2 0.0004
22 INFUSION SITE INFECTION 1 0.0004
23 PATELLA FRACTURE 1 0.0004
24 SLOW SPEECH 1 0.0004
25 HAEMORRHAGE URINARY TRACT 1 0.0004
26 NON-CARDIAC CHEST PAIN 1 0.0003
27 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
28 LUNG TRANSPLANT 1 0.0003
29 RECTAL DISCHARGE 1 0.0003
30 FAECES HARD 1 0.0003
31 INTERVERTEBRAL DISC DISORDER 1 0.0002
32 IMMOBILE 1 0.0002
33 IRON DEFICIENCY 1 0.0002
34 SUSPECTED OFF LABEL USE 1 0.0002
35 PATHOLOGICAL FRACTURE 1 0.0002
36 FAILURE TO THRIVE 1 0.0002
37 STREPTOCOCCAL INFECTION 1 0.0002
38 PERONEAL NERVE PALSY 1 0.0002
39 URINE ODOUR ABNORMAL 1 0.0002
40 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
41 METASTASIS 1 0.0001
42 INJECTION SITE HAEMATOMA 2 0.0001
43 GENERAL SYMPTOM 1 0.0001
44 PYELONEPHRITIS 1 0.0001
45 GRIP STRENGTH DECREASED 1 0.0001
46 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
47 PHOTOPHOBIA 2 0.0001
48 SPUTUM DISCOLOURED 1 0.0001
49 BLOOD URINE PRESENT 2 0.0001
50 SINUS BRADYCARDIA 1 0.0001
51 SINUS DISORDER 2 0.0001
52 BLADDER DISORDER 1 0.0001
53 SUDDEN DEATH 1 0.0001
54 OCULAR DISCOMFORT 1 0.0001
55 NEOPLASM 1 0.0001
56 BLOOD IRON DECREASED 1 0.0001
57 ACCIDENT 1 0.0001
58 MUSCLE SPASTICITY 1 0.0001
59 HIATUS HERNIA 1 0.0001
60 QUALITY OF LIFE DECREASED 1 0.0001
61 UVEITIS 1 0.0001
62 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
63 PARALYSIS 1 0.0001
64 ANOSMIA 1 0.0001
65 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
66 PHARYNGEAL OEDEMA 1 0.0001
67 THERAPY PARTIAL RESPONDER 1 0.0001
68 CYSTITIS 2 0.0001
69 SENSORY DISTURBANCE 1 0.0001
70 MOVEMENT DISORDER 2 0.0001
71 MANIA 1 0.0001
72 SCAR 1 0.0001
73 GASTRIC DISORDER 2 0.0001
74 PARANOIA 1 0.0001
75 DEVICE DEFECTIVE 1 0.0001
76 METASTASES TO LIVER 1 0.0001
77 PRODUCT ADHESION ISSUE 2 0.0001
78 MOBILITY DECREASED 4 0.0001
79 FOOT FRACTURE 1 0.0001
80 MUSCULOSKELETAL DISORDER 1 0.0001
81 KIDNEY INFECTION 1 0.0001
82 FEEDING DISORDER 1 0.0000
83 TASTE DISORDER 1 0.0000
84 RIB FRACTURE 1 0.0000
85 KNEE ARTHROPLASTY 1 0.0000
86 FAECES DISCOLOURED 1 0.0000
87 MUSCULOSKELETAL STIFFNESS 4 0.0000
88 STEVENS-JOHNSON SYNDROME 1 0.0000
89 TOOTH DISORDER 1 0.0000
90 LOCALISED INFECTION 1 0.0000
91 CEREBRAL INFARCTION 1 0.0000
92 ABASIA 1 0.0000
93 AGEUSIA 1 0.0000
94 DRY EYE 2 0.0000
95 HYPOPHAGIA 1 0.0000
96 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
97 JAUNDICE 1 0.0000
98 PAIN OF SKIN 1 0.0000
99 CONSTIPATION 8 0.0000
100 HAEMOPTYSIS 1 0.0000
101 INTENTIONAL DOSE OMISSION 1 0.0000
102 RED BLOOD CELL COUNT DECREASED 1 0.0000
103 BALANCE DISORDER 3 0.0000
104 SURGERY 2 0.0000
105 ASCITES 1 0.0000
106 URINARY INCONTINENCE 1 0.0000
107 BLOOD POTASSIUM DECREASED 1 0.0000
108 LACRIMATION INCREASED 1 0.0000
109 DISCOMFORT 2 0.0000
110 GYNAECOMASTIA 1 0.0000
111 HIP FRACTURE 1 0.0000
112 IMPAIRED HEALING 1 0.0000
113 VIRAL INFECTION 1 0.0000
114 LIP SWELLING 1 0.0000
115 URINARY TRACT INFECTION 5 0.0000
116 NIGHTMARE 1 0.0000
117 SLEEP DISORDER 2 0.0000
118 ACCIDENTAL OVERDOSE 1 0.0000
119 DYSURIA 1 0.0000
120 HOT FLUSH 2 0.0000
121 INTESTINAL OBSTRUCTION 1 0.0000
122 PLASMA CELL MYELOMA 1 0.0000
123 DISORIENTATION 1 0.0000
124 EXTRA DOSE ADMINISTERED 1 0.0000
125 BLINDNESS 1 0.0000
126 DRUG ABUSE 2 0.0000
127 CARDIO-RESPIRATORY ARREST 1 0.0000
128 PRODUCT DOSE OMISSION ISSUE 7 0.0000
129 SKIN EXFOLIATION 2 0.0000
130 MYALGIA 4 0.0000
131 RECTAL HAEMORRHAGE 1 0.0000
132 HYPOACUSIS 1 0.0000
133 ANGIOEDEMA 1 0.0000
134 PRODUCT QUALITY ISSUE 3 0.0000
135 SKIN IRRITATION 1 0.0000
136 SKIN DISCOLOURATION 1 0.0000
137 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
138 RENAL DISORDER 1 0.0000
139 COGNITIVE DISORDER 1 0.0000
140 ARRHYTHMIA 1 0.0000
141 RENAL CANCER 1 0.0000
142 MIGRAINE 2 0.0000
143 PRODUCTIVE COUGH 1 0.0000
144 MULTIPLE SCLEROSIS 1 0.0000
145 GAIT DISTURBANCE 4 0.0000
146 BLOOD GLUCOSE DECREASED 1 0.0000
147 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
148 CELLULITIS 1 0.0000
149 THERAPY CESSATION 1 0.0000
150 INFLAMMATION 1 0.0000
151 DRUG EFFECT DECREASED 1 0.0000
152 RASH PRURITIC 1 0.0000
153 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
154 MEDICATION ERROR 1 0.0000
155 FLATULENCE 1 0.0000
156 MUSCULAR WEAKNESS 2 0.0000
157 HERPES ZOSTER 1 0.0000
158 PRODUCT SUBSTITUTION ISSUE 1 0.0000
159 COVID-19 3 0.0000
160 BONE PAIN 1 0.0000
161 NASAL CONGESTION 1 0.0000
162 BLADDER CANCER 1 0.0000
163 RHINORRHOEA 1 0.0000
164 AMNESIA 1 0.0000
165 ALOPECIA 3 0.0000
166 DEHYDRATION 2 0.0000
167 SOMNOLENCE 3 0.0000
168 VISION BLURRED 2 0.0000
169 MEMORY IMPAIRMENT 2 0.0000
170 WEIGHT DECREASED 4 0.0000
171 COUGH 4 0.0000
172 DEVICE MALFUNCTION 1 0.0000
173 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
174 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
175 THERAPY INTERRUPTED 1 0.0000
176 SKIN BURNING SENSATION 1 0.0000
177 INFECTION 2 0.0000
178 MALAISE 6 0.0000
179 PAIN IN EXTREMITY 4 0.0000
180 BRONCHITIS 1 0.0000
181 EPISTAXIS 1 0.0000
182 HALLUCINATION 1 0.0000
183 ACNE 1 0.0000
184 BACK PAIN 3 0.0000
185 ARTHRITIS 1 0.0000
186 INJECTION SITE BRUISING 1 0.0000
187 CARDIAC FAILURE 1 0.0000
188 PROSTATE CANCER 1 0.0000
189 DIARRHOEA 8 0.0000
190 PNEUMONIA 4 0.0000
191 ARTHRALGIA 5 0.0000
192 MYOCARDIAL INFARCTION 2 0.0000
193 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
194 ADVERSE EVENT 1 0.0000
195 OROPHARYNGEAL PAIN 1 0.0000
196 CHEST PAIN 2 0.0000
197 VOMITING 5 0.0000
198 ANAEMIA 2 0.0000
199 FATIGUE 8 0.0000
200 ATRIAL FIBRILLATION 1 0.0000
201 CONDITION AGGRAVATED 3 0.0000
202 HAEMOGLOBIN DECREASED 1 0.0000
203 HEADACHE 6 0.0000
204 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
205 THROMBOCYTOPENIA 1 0.0000
206 DEPRESSION 2 0.0000
207 SEIZURE 1 0.0000
208 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
209 DECREASED APPETITE 2 0.0000
210 ABDOMINAL PAIN 2 0.0000
211 PALPITATIONS 1 0.0000
212 FEELING ABNORMAL 2 0.0000
213 DRUG INEFFECTIVE 11 0.0000
214 PAIN 5 0.0000
215 ASTHENIA 3 0.0000
216 LOSS OF CONSCIOUSNESS 1 0.0000
217 HYPERHIDROSIS 1 0.0000
218 INSOMNIA 2 0.0000
219 RASH 3 0.0000
220 OFF LABEL USE 6 0.0000
221 HYPOAESTHESIA 1 0.0000
222 HOSPITALISATION 1 0.0000
223 PARAESTHESIA 1 0.0000
224 NAUSEA 5 0.0000
225 DRUG INTERACTION 1 0.0000
226 CONFUSIONAL STATE 1 0.0000
227 DRUG DOSE OMISSION 1 0.0000
228 DIZZINESS 3 0.0000
229 FALL 2 0.0000
230 URTICARIA 1 0.0000
231 ABDOMINAL DISCOMFORT 1 0.0000
232 TOXICITY TO VARIOUS AGENTS 1 0.0000
233 NO ADVERSE EVENT 1 0.0000
234 MUSCLE SPASMS 1 0.0000
235 NASOPHARYNGITIS 1 0.0000
236 HYPERSENSITIVITY 1 0.0000
237 DYSPNOEA 3 0.0000
238 PRURITUS 2 0.0000
239 HYPOTENSION 1 0.0000
240 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
241 ERYTHEMA 1 0.0000
242 HYPERTENSION 1 0.0000
243 OVERDOSE 1 0.0000
244 WEIGHT INCREASED 1 0.0000
245 PYREXIA 1 0.0000
246 DEATH 2 0.0000